Scott Koenig - 01 Jun 2023 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
GLYC
Transactions as of
01 Jun 2023
Net transactions value
+$12,600
Form type
4
Filing time
02 Jun 2023, 16:10:27 UTC
Previous filing
22 May 2023
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Options Exercise $12,600 +21,000 +133% $0.6000 36,750 01 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLYC Stock option (right to buy) Options Exercise $0 -21,000 -100% $0.000000* 0 01 Jun 2023 Common Stock 21,000 $0.6000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vested on May 18, 2023 and are fully exercisable.